Status:
RECRUITING
Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Cancers are often treated with external beam radiotherapy. Current radiotherapy treatments are performed using computed tomography (also known as CT) scans which may not always clearly identify the ca...
Detailed Description
This prospective, open-label, Phase I/II, clinical trial is feasibility study to evaluate MR-guided radiotherapy with the Alberta linac-MR P3 system in adult patients with cancer that are treated with...
Eligibility Criteria
Inclusion
- Adults ≥ 18 years of age
- Patients deemed fit to undergo external beam radiation therapy by their attending radiation oncologist
- Accessible for follow-up
Exclusion
- Patients with contraindications for MRI
- Patients who are unable to lie flat and still for the duration of the expected scan acquisition and treatment
- Patients who are unable to provide informed consent
- Patients with clinically significant inferior treatment plans compared to standard CT based external beam plans. For example, plans that generate hot spots of \> 110% or other unacceptable treatment plans that would not otherwise arise with standard CT based external beam plans.
- Pregnancy
Key Trial Info
Start Date :
February 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT05413473
Start Date
February 8 2023
End Date
January 1 2030
Last Update
June 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2